Novo Nordisk nears EU okay for oral GLP-1 drug Rybelsus afte...

The EMA's main advisory committee has backed approval of Novo Nordisk's oral GLP-1 agonist Rybelsus, a key pipeline drug in its type 2 diabetes franchise.

Alnylam gets CHMP backing for second gene-silencing drug Giv...

Merck’s last-resort antibiotic Recarbrio nears EU approval

CHMP okays Sanofi’s Zynquista in type 1 diabetes

Sanofi has moved a step closer to getting its new diabetes therapy Zynquista approved in Europe, with a positive opinion from the Committee for Medicinal Products for Human Use (CHMP).

Europe's CHMP regulatory committee has new chair

Europe’s top drugs regulatory committee has a new leader after Dr Tomas Salmonson stepped down as chair of the CHMP after six years.

Takeda finalises buyout of TiGenix

Japanese pharma giant Takeda has completed its buyout of TiGenix.